A 90-count $4.3 million dollar lawsuit against the makers of the blood thinner medication known as Xarelto has been added to the multi-district litigation (MDL) cases which are now being handled in the U.S. District Court for the Eastern District of Louisiana.
U.S. District Court Judge Eldon E. Fallon is presiding over the more than 250 Xarelto lawsuit cases that are now part of the MDL proceedings.
Xarelto is a blood thinner medication or anticoagulant drug used to treat a range of different medical conditions including deep vein thrombosis, pulmonary embolism, stroke and blood clots, particularly in patients who’ve undergone joint replacement surgery on their hips or knees.
This $4.3 million lawsuit originated in Madison County, Illinois, where plaintiff Sonja Lemoins filed the complaint on January 22, 2015. Lemoins’ lawsuit faults the drug’s manufacturers for marketing it as a “safe” treatment for pulmonary embolism and stroke.
The Illinois woman alleges that Xarelto and its manufacturers are guilty of negligence, negligent misrepresentation, strict product liability, common law fraud, intentional infliction of emotional distress and negligent infliction of emotional distress, amongst other claims.
Many patients have claimed that Xarelto, manufactured by Janssen Pharmaceuticals, a division of Bayer, over-played positive study results while placing little emphasis on the dangers of the drug, including gastrointestinal bleeding and other uncontrolled bleeding problems. Xarelto has also been linked with blood clots — a problem that the drug was reportedly designed to prevent.
Many of the lawsuits also fault the anticoagulant drug makers for releasing a drug that does not have an antidote, calling it negligent. Notably, the other most common blood thinner on the market is coumadin/warfarin. Its effects can be reversed with doses of Vitamin K, although the drug requires frequent testing in order to maintain therapeutic levels. This is why many patients favored Xarelto, yet some say they were never notified of the fact that there’s no antidote.
Notably, news reports indicate that Xarelto spent over $11 million dollars on advertisements and promotions for the drug, with sales topping $580 million in just one year alone. Critics say these advertisements overstated the efficacy of the medication, while downplaying the risks and dangers.
If you’ve suffered medical complications as a result of taking Xarelto, there is still time to take action. But it’s important to note that the law limits the amount of time you have to take action in a personal injury case, so acting promptly is critical.
The Meldofsky Law Firm is currently accepting new clients who have suffered physical injury, financial losses and emotional trauma as a result of complications from the blood thinner known as Xarelto. Contact the Meldofsky Law Firm by phone at 877-274-8672.